|
Name |
3alpha-hydroxy-3,5-dihydromonacolin L acid
|
Molecular Formula | C19H32O5 | |
IUPAC Name* |
(3R,5R)-7-[(1R,2R,3S,6R,8aR)-3-hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
|
|
SMILES |
C[C@@H]1CC[C@@H]2[C@H]([C@H]([C@@H](C=C2C1)O)C)CC[C@H](C[C@H](CC(=O)O)O)O
|
|
InChI |
InChI=1S/C19H32O5/c1-11-3-5-17-13(7-11)8-18(22)12(2)16(17)6-4-14(20)9-15(21)10-19(23)24/h8,11-12,14-18,20-22H,3-7,9-10H2,1-2H3,(H,23,24)/t11-,12-,14-,15-,16+,17+,18-/m1/s1
|
|
InChIKey |
MRKCPMGQBNMKTA-GBRHIFDWSA-N
|
|
Synonyms |
3alpha-hydroxy-3,5-dihydromonacolin L acid; 113855-37-1; 3alpha-Hydroxy-3,5-dihydromonacolin L; 3-Hydroxy-3,5-dihydromonacolin L; 3-ADML; (3r,5r)-3,5-dihydroxy-7-[(1r,2r,3s,6r,8ar)-3-hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1R,2R,3S,6R,8aR)-3-hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; CHEBI:82972; DTXSID00921221; C20852; Q27156514; (3R,5R)-7-[(1R,2R,3S,6R,8aR)-3-Hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate; (3R,5R)-7-[[(1R)-1,2,3,5,6,7,8,8abeta-Octahydro-3alpha-hydroxy-2beta,6alpha-dimethylnaphthalen]-1beta-yl]-3,5-dihydroxyheptanoic acid; 3,5-dihydroxy-7-(3-hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl)heptanoic acid
|
|
CAS | 113855-37-1 | |
PubChem CID | 195046 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 340.5 | ALogp: | 1.9 |
HBD: | 4 | HBA: | 5 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 98.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 24 | QED Weighted: | 0.534 |
Caco-2 Permeability: | -5.607 | MDCK Permeability: | 0.00004440 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.999 |
Human Intestinal Absorption (HIA): | 0.064 | 20% Bioavailability (F20%): | 0.891 |
30% Bioavailability (F30%): | 0.985 |
Blood-Brain-Barrier Penetration (BBB): | 0.095 | Plasma Protein Binding (PPB): | 82.83% |
Volume Distribution (VD): | 0.393 | Fu: | 10.08% |
CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.104 |
CYP2C19-inhibitor: | 0.015 | CYP2C19-substrate: | 0.832 |
CYP2C9-inhibitor: | 0.015 | CYP2C9-substrate: | 0.969 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.092 |
CYP3A4-inhibitor: | 0.012 | CYP3A4-substrate: | 0.109 |
Clearance (CL): | 7.243 | Half-life (T1/2): | 0.904 |
hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.611 |
Drug-inuced Liver Injury (DILI): | 0.556 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.294 | Maximum Recommended Daily Dose: | 0.973 |
Skin Sensitization: | 0.184 | Carcinogencity: | 0.277 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.186 |
Respiratory Toxicity: | 0.894 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006008 | 0.472 | D02RQU | 0.431 | ||||
ENC001102 | 0.412 | D01WUA | 0.286 | ||||
ENC006006 | 0.342 | D05ZTH | 0.245 | ||||
ENC002332 | 0.270 | D0C6NM | 0.236 | ||||
ENC004385 | 0.269 | D0N3NO | 0.230 | ||||
ENC004384 | 0.269 | D06WTZ | 0.229 | ||||
ENC004701 | 0.256 | D0V0IX | 0.227 | ||||
ENC005834 | 0.255 | D0M4WA | 0.225 | ||||
ENC004295 | 0.248 | D0OR2L | 0.220 | ||||
ENC005891 | 0.242 | D0I4DQ | 0.218 |